GW Pharmaceuticals Total Assets 2013-2018 | GWPH

GW Pharmaceuticals total assets from 2013 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • GW Pharmaceuticals total assets for the quarter ending September 30, 2018 were $0.491B, a 10.75% increase year-over-year.
  • GW Pharmaceuticals total assets for 2018 were $0.491B, a 10.75% increase from 2017.
  • GW Pharmaceuticals total assets for 2017 were $0.443B, a 31.39% decline from 2016.
  • GW Pharmaceuticals total assets for 2016 were $0.646B, a 45.36% increase from 2015.
GW Pharmaceuticals Annual Total Assets
(Millions of US $)
2018 $491
2017 $443
2016 $646
2015 $444
2014 $314
2013 $95
2012 $68
GW Pharmaceuticals Quarterly Total Assets
(Millions of US $)
Q4 2018 $491
Q3 2018 $579
Q2 2018 $629
Q1 2017 $693
Q4 2017 $443
Q3 2017 $474
Q2 2017 $501
Q1 2016 $549
Q4 2016 $646
Q3 2016 $346
Q2 2016 $378
Q1 2015 $418
Q4 2015 $444
Q3 2015 $469
Q2 2015 $276
Q1 2014 $300
Q4 2014 $314
Q3 2014 $335
Q2 2014 $203
Q1 2013 $101
Q4 2013 $95
Q3 2013 $96
Q2 2013 $68
Q1 2012 $0
Q4 2012 $68
Q3 2012 $0
Q2 2012 $59
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.086B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14